ACADIAN ASSET MANAGEMENT LLC

Position in NVCR — NovoCure Ltd

CIK 916542 Boston, MA

Position in NVCR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,857,402

-$492,476 QoQ

Shares Held

262,147

+1.2% QoQ

Ownership

0.226%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $1,019,768,081 across 54 Medical Devices names. NVCR ranks #26 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	3,222,118	$330,814,855
2	SYK	Stryker Corp	449,052	$147,553,996
3	BSX	Boston Scientific Corp	1,495,140	$93,820,035
4	MDT	Medtronic plc	828,643	$71,801,915
5	EW	Edwards Lifesciences Corp	818,164	$65,518,573
6	PODD	Insulet Corp	256,584	$53,841,586
7	INMD	InMode Ltd.	2,593,203	$35,475,017
8	DXCM	Dexcom Inc	463,647	$29,117,031

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,857,402	262,147	+1.2%	Shares	Defined	2026-05-13
2025-12-31	$3,349,878	259,078	+24.0%	Shares	Defined	2026-02-10
2025-09-30	$2,699,091	208,908	+297.7%	Shares	Defined	2025-11-13
2025-06-30	$934,945	52,525	+965.6%	Shares	Defined	2025-08-07
2025-03-31	$87,834	4,929	-43.4%	Shares	Defined	2025-05-21
2024-09-30	$136,168	8,712	+177.2%	Shares	Defined	2024-11-12
2024-03-31	$49,125	3,143	-92.6%	Shares	Defined	2024-05-10
2023-12-31	$637,466	42,697	+693.9%	Shares	Defined	2024-02-13
2023-09-30	$86,854	5,378	+74.0%	Shares	Defined	2023-11-13
2020-12-31	$534,866	3,091	+190.2%	Shares	Defined	2021-02-11
2020-09-30	$118,545	1,065	-50.0%	Shares	Defined	2020-11-09
2020-06-30	$126,427	2,132	+5.4%	Shares	Defined	2020-08-12
2020-03-31	$136,228	2,023	—	Shares	Defined	2020-05-11
No filing history on record for this holder in this stock.